314930 — Biodyne Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩256bn
- KR₩237bn
- KR₩4bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,817 | 3,984 | 25,461 | 20,735 | 19,726 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,950 | 1,545 | 1,055 | 605 | 754 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5,081 | 6,690 | 27,987 | 22,915 | 21,134 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10,239 | 10,639 | 11,310 | 11,531 | 11,293 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 23,251 | 25,245 | 45,823 | 45,414 | 43,986 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,815 | 5,578 | 7,313 | 1,254 | 604 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 16,675 | 18,242 | 7,324 | 1,255 | 604 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 6,576 | 7,002 | 38,498 | 44,159 | 43,382 |
Total Liabilities & Shareholders' Equity | 23,251 | 25,245 | 45,823 | 45,414 | 43,986 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |